Compare ImmunityBio Inc. Common Stock (IBRX) vs IQVIA Holdings Inc. Common Stock (IQV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs IQVIA Holdings Inc. Common Stock — how do they compare? ImmunityBio Inc. Common Stock trades at $10.58 (market cap $10.51B), while IQVIA Holdings Inc. Common Stock trades at $261.91 (market cap $42.61B). The key difference: IQVIA Holdings Inc. Common Stock is far larger — about 4.1× ImmunityBio Inc. Common Stock's market cap, and IQVIA Holdings Inc. Common Stock is more actively traded (988,398 versus 10,445,785). Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and IQVIA Holdings Inc. Common Stock for 0 Days on average.
| IBRX | IQV | |
|---|---|---|
Market Cap | $10.51B | $42.61B |
Volume | 10,445,785 | 988,398 |
Sector | Health | Health |
52-Week High | $11.55 | $275.02 |
52-Week Low | $1.98 | $156.66 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.97B | $56.77B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About IQVIA Holdings Inc. Common Stock
IQVIA provides clinical research, healthcare data, technology, and consulting services to life sciences companies. Its work supports drug development and commercialization.
Read more on IQV →
